LONDON, UK, 14 June, 2012 - SkyePharma PLC (LSE: SKP) today announces in accordance with Listing Rule 9.6.14R, that Dr Thomas Werner, a Non-Executive Director of the Company, has been appointed from 13 June 2012 as Chairman of 4SC AG which is listed on Xetra and all German stock exchanges. Dr Werner has been a Director of 4SC AG since June 2009.
For further information please contact:
Peter Grant, Chief Executive Officer
+44 207 881 0524
This information is provided by RNS
The company news service from the London Stock Exchange
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.